Clinical trial
The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non…
NCT00484263 · The Alfred, Other · Completed
Key facts
| NCT number | NCT00484263 |
|---|---|
| Title | The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis |
| Official title | The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non-cystic Fibrosis Bronchiectasis. |
| Lead sponsor | The Alfred, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bronchiectasis |
| Intervention type | Drug |
| Interventions | Hypertonic saline 6% - |
| Enrollment | 40 |
| Start date | Dec 1, 2007 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Jun 8, 2007 |
| Last update posted | Jun 23, 2011 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: